Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects - Mundasad, M V; Novack, G D; Allgood, V E; Evans, R M; Gorden, J C; Yerxa, B R (Journal of ocular pharmacology and therapeutics, 2001)
Keywords: Administration, Topical; Adult; Cohort Studies; Double-Blind Method; Dry Eye Syndromes - drug therapy; Female; Humans; Lacrimal Apparatus - drug effects; Lacrimal Apparatus - secretion; Male; Middle Aged; Mucins - metabolism; Ophthalmic Solutions - administration & dosage; Ophthalmic Solutions - adverse effects; Ophthalmic Solutions - pharmacology; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2 - metabolism; Safety; Tears - secretion; Uracil Nucleotides